NewMarket Corporation (NYSE:NEU) shares moved down -0.26% in last trading session and ended the day at $396.26. NEU Gross Margin is 31.70% and its has a return on assets of 18.60%. NewMarket Corporation (NYSE:NEU) quarterly performance is 3.52%.
Kadant Inc. (NYSE:KAI) ended the last trading day at $45.16. Company weekly volatility is calculated as 2.94% and price to cash ratio as 7.43. Kadant Inc. (NYSE:KAI) showed a weekly performance of 2.40%.
Kadant Inc. (NYSE:KAI) announced that its Board of Directors approved a 12% increase to its quarterly cash dividend to stockholders to $0.19 per share to be paid on May 12, 2016 to stockholders of record as of the close of business on April 14, 2016. Future declarations of dividends are subject to Board approval and may be adjusted as business needs or market conditions change.
On 31 March, JA Solar Holdings Co., Ltd. (NASDAQ:JASO) shares moved down -0.58% and was closed at $8.61. JASO EPS growth in last 5 year was 26.20%. JA Solar Holdings Co., Ltd. (NASDAQ:JASO) year to date (YTD) performance is -11.24%.
On 15 March, JA Solar Holdings Co., Ltd. (NASDAQ:JASO) announced its unaudited financial results for its fourth quarter and fiscal year ended December 31, 2015. Shipments of modules and module tolling were 1,297.6 MW, increases of +47.5% y/y and +20.8% sequentially
GlobeImmune Inc. (NASDAQ:GBIM) shares advanced 11.17% in last trading session and ended the day at $2.09. GBIM Gross Margin is 95.40% and its has a return on assets of -24.50%. GlobeImmune Inc. (NASDAQ:GBIM) quarterly performance is -55.15%.
GlobeImmune Inc. (NASDAQ:GBIM) provided an update on the Company’s business and clinical programs and announced financial results for the full year ended December 31, 2015. The Company continues to seek potential strategic transactions and, after a thorough process, has not identified a potential transaction to date. Cantor Fitzgerald & Co. has been retained by the Company to assist in reviewing ways to maximize stockholder value. There is not a defined timeline for the strategic review process and the review may not result in any specific action or transaction.
Galena Biopharma Inc (NASDAQ:GALE) caters to the Healthcare space. Its weekly performance is 18.26%. On the last day of trading company shares ended up at $1.36. Galena Biopharma Inc (NASDAQ:GALE) distance from 50-day simple moving average (SMA50) is 6.24%.
Galena Biopharma Inc (NASDAQ:GALE) announced the Company had a typographical error in its Form 10-K filed with the SEC on March 10, 2016 regarding a governmental investigation by the U.S. Attorney’s Office for the Southern District of Alabama.
Leave a Reply